Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals, 33914 [2023-11177]
Download as PDF
<![CDATA[
33914
Federal Register / Vol. 88, No. 101 / Thursday, May 25, 2023 / Notices
(Cannabis) as botanical raw material
and/or active pharmaceutical
ingredients (API) to DEA research
registrants and manufacturers. No other
activities for these drug codes are
authorized for this registration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1202]
Bulk Manufacturer of Controlled
Substances Application: Royal
Emerald Pharmaceuticals
Matthew Strait,
Deputy Assistant Administrator.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
[FR Doc. 2023–11177 Filed 5–24–23; 8:45 am]
Royal Emerald
Pharmaceuticals has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 24, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on March 27, 2023, Royal
Emerald Pharmaceuticals, 14011 Palm
Drive, Building B, Desert Hot Springs,
California 92240–6845, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
DEPARTMENT OF JUSTICE
AGENCY:
BILLING CODE P
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Drug
code
Schedule
7350
7360
7370
I
I
I
The company plans to bulk
manufacture the listed controlled
substances to provide Marihuana
VerDate Sep<11>2014
18:04 May 24, 2023
Jkt 259001
Drug Enforcement Administration
Controlled substance
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7437
7438
I
I
The company plans to bulk
manufacture the listed controlled
substances as Active Pharmaceutical
Ingredients (API) for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–11175 Filed 5–24–23; 8:45 am]
[Docket No. DEA–1200]
BILLING CODE P
Bulk Manufacturer of Controlled
Substances Application: Promega
Corporation
Drug Enforcement Administration
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
[Docket No. DEA–1192]
Promega Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 24, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 24, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on April 5, 2023, Promega
Corporation, 3075 Sub Zero Parkway,
Fitchburg, Wisconsin 53719, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUMMARY:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: Unither Manufacturing
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Unither Manufacturing LLC
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before June 26, 2023. Such
persons may also file a written request
for a hearing on the application on or
before June 26, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
SUMMARY:
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 88, Number 101 (Thursday, May 25, 2023)]
[Notices]
[Page 33914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11177]
[[Page 33914]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1202]
Bulk Manufacturer of Controlled Substances Application: Royal
Emerald Pharmaceuticals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Royal Emerald Pharmaceuticals has applied to be registered as
a bulk manufacturer of basic class(es) of controlled substance(s).
Refer to Supplementary Information listed below for further drug
information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 24, 2023. Such persons may also file a written request for a
hearing on the application on or before July 24, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 27, 2023, Royal Emerald Pharmaceuticals, 14011
Palm Drive, Building B, Desert Hot Springs, California 92240-6845,
applied to be registered as a bulk manufacturer of the following basic
class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances to provide Marihuana (Cannabis) as botanical raw material
and/or active pharmaceutical ingredients (API) to DEA research
registrants and manufacturers. No other activities for these drug codes
are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-11177 Filed 5-24-23; 8:45 am]
BILLING CODE P
